C
Compass Therapeutics Inc.
NASDAQ:CMPX
Compass Therapeutics Inc.
NASDAQ:CMPX
Price:
5.21
USD
-2.25%
Market Closed
Market Cap:
$938.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
Nevada Zinc Corp
XTSX:NZN
|
CA |
|
Uday Jewellery Industries Ltd
BSE:539518
|
IN |
|
A
|
Altos Hornos de Mexico SAB de CV
BMV:AHMSA
|
MX |
|
Aaron's Company Inc
NYSE:AAN
|
US |
|
P
|
Pressure Sensitive Systems India Ltd
BSE:526773
|
IN |
|
Accel SAB de CV
BMV:ACCELSAB
|
MX |
|
H
|
Hartalega Holdings Bhd
KLSE:HARTA
|
MY |
|
W
|
Windward Ltd
LSE:WNWD
|
IL |
|
I
|
IWS Group Holdings Ltd
HKEX:6663
|
HK |
|
A
|
Anhui Genuine New Materials Co Ltd
SSE:603429
|
CN |
Balance Sheet
Balance Sheet Decomposition
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Balance Sheet Decomposition is not available for
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Balance Sheet
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
58
|
25
|
47
|
145
|
35
|
24
|
43
|
31
|
|
| Cash Equivalents |
58
|
25
|
47
|
145
|
35
|
24
|
43
|
31
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
152
|
128
|
83
|
178
|
|
| Other Current Assets |
1
|
1
|
3
|
3
|
8
|
1
|
6
|
1
|
|
| Total Current Assets |
59
|
26
|
50
|
147
|
195
|
154
|
133
|
210
|
|
| PP&E Net |
5
|
4
|
1
|
6
|
5
|
3
|
7
|
9
|
|
| PP&E Gross |
5
|
4
|
1
|
6
|
5
|
3
|
7
|
9
|
|
| Accumulated Depreciation |
4
|
6
|
6
|
5
|
6
|
6
|
6
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
65
N/A
|
30
-53%
|
52
+71%
|
154
+196%
|
200
+30%
|
157
-21%
|
140
-11%
|
220
+56%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
3
|
4
|
2
|
2
|
|
| Accrued Liabilities |
3
|
3
|
2
|
10
|
13
|
4
|
7
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
6
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
9
|
10
|
10
|
11
|
16
|
8
|
9
|
14
|
|
| Long-Term Debt |
11
|
9
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
2
|
1
|
6
|
9
|
|
| Total Liabilities |
20
N/A
|
19
-2%
|
12
-37%
|
14
+14%
|
18
+31%
|
8
-54%
|
15
+82%
|
23
+50%
|
|
| Equity | |||||||||
| Common Stock |
132
|
133
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
87
|
122
|
151
|
234
|
273
|
315
|
365
|
431
|
|
| Additional Paid In Capital |
0
|
0
|
191
|
374
|
455
|
464
|
490
|
628
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
45
N/A
|
11
-75%
|
40
+253%
|
140
+251%
|
182
+30%
|
149
-18%
|
125
-16%
|
197
+57%
|
|
| Total Liabilities & Equity |
65
N/A
|
30
-53%
|
52
+71%
|
154
+196%
|
200
+30%
|
157
-21%
|
140
-11%
|
220
+56%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
52
|
52
|
51
|
101
|
126
|
128
|
138
|
178
|
|
Switch to:
Switch to:
See Also
Discover More
